• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon.

作者信息

Andres Sönke, Merker Matthias, Heyckendorf Jan, Kalsdorf Barbara, Rumetshofer Rudolf, Indra Alexander, Hofmann-Thiel Sabine, Hoffmann Harald, Lange Christoph, Niemann Stefan, Maurer Florian P

机构信息

Research Center BorstelBorstel, Germany.

German Center for Infection ResearchBorstel, Germany.

出版信息

Am J Respir Crit Care Med. 2020 Jun 15;201(12):1564-1568. doi: 10.1164/rccm.201909-1819LE.

DOI:10.1164/rccm.201909-1819LE
PMID:32053752
Abstract
摘要

相似文献

1
Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon.耐贝达喹啉结核病：地平线上的乌云。
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1564-1568. doi: 10.1164/rccm.201909-1819LE.
2
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis.pepQ基因突变赋予结核分枝杆菌对贝达喹啉和氯法齐明的低水平耐药性。
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4590-9. doi: 10.1128/AAC.00753-16. Print 2016 Aug.
3
Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline.耐多药结核病及其他情况：关于贝达喹啉现有证据的最新分析
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.00146-2017. Print 2017 Mar.
4
Clofazimine Exposure Selects Efflux Pump Mutants and Bedaquiline Resistance.氯法齐明暴露选择外排泵突变体和贝达喹啉耐药性。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02141-18. Print 2019 Mar.
5
Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.在使用贝达喹啉治疗耐多药结核病后获得氯法齐明耐药性。
Int J Infect Dis. 2021 Jan;102:392-396. doi: 10.1016/j.ijid.2020.10.081. Epub 2020 Oct 29.
6
Rapid emergence of bedaquiline resistance: lessons to avoid repeating past errors.贝达喹啉耐药性的迅速出现：避免重蹈覆辙的教训。
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.01719-2016. Print 2017 Mar.
7
Bedaquiline.贝达喹啉
Br J Clin Pharmacol. 2015 Aug;80(2):182-4. doi: 10.1111/bcp.12613. Epub 2015 Jul 2.
8
Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.结核病治疗中对贝达喹啉和地拉马尼的获得性耐药性。
N Engl J Med. 2015 Nov 12;373(20):1986-8. doi: 10.1056/NEJMc1505196.
9
Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.结核病治疗停止后贝达喹啉的微异质性耐药
N Engl J Med. 2019 May 30;380(22):2178-2180. doi: 10.1056/NEJMc1815121.
10
Multidrug-resistant tuberculosis and bedaquiline.耐多药结核病与贝达喹啉
N Engl J Med. 2014 Dec 18;371(25):2435-6. doi: 10.1056/NEJMc1412235.

引用本文的文献

1
Development of tolerance to bedaquiline by overexpression of trypanosomal acetate: succinate CoA transferase in Mycobacterium smegmatis.通过在耻垢分枝杆菌中过表达锥虫乙酸盐：琥珀酸辅酶A转移酶来产生对贝达喹啉的耐受性。
Commun Biol. 2025 Feb 6;8(1):187. doi: 10.1038/s42003-025-07611-0.
2
Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.对印度结核患者临床分离株进行全基因组测序：真实世界数据显示存在较高比例的预广泛耐药病例。
Microbiol Spectr. 2024 May 2;12(5):e0277023. doi: 10.1128/spectrum.02770-23. Epub 2024 Apr 10.
3
Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis.
检测结核分枝杆菌中与贝达喹啉/氯法齐明耐药相关变异的历史储存库。
Genome Med. 2024 Feb 19;16(1):34. doi: 10.1186/s13073-024-01289-5.
4
Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone.塞拉利昂耐多药结核病的分子决定因素。
Microbiol Spectr. 2024 Mar 5;12(3):e0240523. doi: 10.1128/spectrum.02405-23. Epub 2024 Jan 30.
5
Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against .氯法齐明和贝达喹啉的耐药分子机制及治疗效果
Front Med (Lausanne). 2024 Jan 10;10:1304857. doi: 10.3389/fmed.2023.1304857. eCollection 2023.
6
Addressing the needs of people with extensively drug-resistant TB through pre-approval access to drugs and research.通过预先批准药物获取和研究来满足广泛耐药结核病患者的需求。
Public Health Action. 2023 Dec;13(4):126-129. doi: 10.5588/pha.23.0033. Epub 2023 Dec 7.
7
Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysis.基线和治疗中出现的贝达喹啉耐药性在耐药性肺结核中的：系统评价和荟萃分析。
Eur Respir J. 2023 Dec 14;62(6). doi: 10.1183/13993003.00639-2023. Print 2023 Dec.
8
Clustering minimal inhibitory concentration data through Bayesian mixture models: An application to detect resistance mutations.通过贝叶斯混合模型对最小抑菌浓度数据进行聚类：一种用于检测耐药突变的应用。
Stat Methods Med Res. 2023 Dec;32(12):2423-2439. doi: 10.1177/09622802231211010. Epub 2023 Nov 3.
9
High and Low Levels of Expression Are Associated with Two Distinct Gene Signatures in Lung Tissue of Pulmonary TB Patients with High Inflammation Activity.高表达和低表达水平与高炎症活动期肺结核患者肺组织中的两个不同基因特征相关。
Int J Mol Sci. 2023 Oct 2;24(19):14839. doi: 10.3390/ijms241914839.
10
Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting .发现、合成和优化 1,2,4-三唑并吡啶类化合物靶向.
ACS Infect Dis. 2023 Nov 10;9(11):2282-2298. doi: 10.1021/acsinfecdis.3c00341. Epub 2023 Oct 3.